secwatch / observer
8-K filed May 5, 2026, 7:59 PM ET ticker CVGI CIK 0001290900
earnings confidence high sentiment neutral materiality 0.50

CVG Q1 revenue up 1% to $171.5M; EPS $0.03; adjusted EBITDA $4.8M, down 17%

Commercial Vehicle Group, Inc.

item 2.02item 7.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001628280-26-030670
form_type
8-K
ticker
CVGI
cik
0001290900
company_name
Commercial Vehicle Group, Inc.
filed_at
2026-05-05T23:59:59+00:00
discovered_at
2026-05-14T18:02:32.099399+00:00
generated_at
2026-05-14T23:15:56.474597+00:00
sec_items
["2.02", "7.01", "9.01"]
event_type
earnings
sentiment
neutral
materiality_score
0.5
calibrated_materiality_score
0.5
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001628280-26-030670
json_url
https://secwatch.observer/filing/0001628280-26-030670.json
markdown_url
https://secwatch.observer/filing/0001628280-26-030670.md
text_url
https://secwatch.observer/filing/0001628280-26-030670.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1290900/000162828026030670/0001628280-26-030670-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1290900/000162828026030670/cvgi-20260505.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

db96f439e4c9d7d9a1a16c0dbf61e2adc81e7b80

Commercial Vehicle Group, Inc. reported first quarter ended March 31, 2026 results: revenue $171.5 million, net income $0.9 million, EPS $0.03 per diluted share. Guidance reaffirmed.

• Revenues of $171.5 million, up 1.0%, primarily driven by 14% growth in our Global Electrical Systems segment. • Operating income of $14.7 million, which included $14.0 million gain on sale of assets, was up $13.3 million, compared to $1.4 million. Adjusted operating income of $2.0 million, relatively flat compared to $2.1 million. • Net income from continuing operations of $0.9 million, or $0.03 per diluted share and adjusted net loss of $3.4 million, or $(0.10) per diluted share, compared to net loss from continuing operations of $3.1 million, or $(0.09) per diluted share and adjusted net loss of $2.6 million, or $(0.08) per diluted share.

SEC 8-K Item 2.02 confidence 0.95 SEC evidence

Comparable filings

POLA

Polar Power Q1 net loss narrows 86% to $178K; gross margin expands to 65.7%

Polar Power, Inc. June 2, 2026, 8:30 AM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

• Revenues of $171.5 million, up 1.0%, primarily driven by 14% growth in our Global Electrical Systems segment. • Operating income of $14.7 million, which included $14.0 million gain on sale of assets, was up $13.3 million, compared to $1.4 million. Adjusted operating income of $2.0 million, relatively flat compared to $2.1 million. • Net income from continuing operations of $0.9 million, or $0.03 per diluted share and adjusted net loss of $3.4 million, or $(0.10) per diluted share, compared to net loss from continuing operations of $3.1 million, or $(0.09) per diluted share and adjusted net loss of $2.6 million, or $(0.08) per diluted share.

Comparable filing

Q1 2026 Q1 2025 Y/Y +/(-) Change Net sales $ 1,728 $ 1,723 — Gross profit $ 1,135 $ 320 255 % Gross margin 65.7 % 18.6 % 47.1 pts Total operating expenses $ 1,111 $ 1,421 22 % Income (loss) from operations $ 24 $ (1,101 ) 102 % Net loss $ (178 ) $ (1,265 ) 86 % Net loss per share $ (0.05 ) $ (0.50 ) 90 %

Filing page SEC filing

EXPI

eXp World Holdings Q1 revenue $1.0B (+5% YoY), net loss narrows to $(5.1M), Adj. EBITDA $4.1M (+88%)

eXp World Holdings, Inc. May 11, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

• Revenues of $171.5 million, up 1.0%, primarily driven by 14% growth in our Global Electrical Systems segment. • Operating income of $14.7 million, which included $14.0 million gain on sale of assets, was up $13.3 million, compared to $1.4 million. Adjusted operating income of $2.0 million, relatively flat compared to $2.1 million. • Net income from continuing operations of $0.9 million, or $0.03 per diluted share and adjusted net loss of $3.4 million, or $(0.10) per diluted share, compared to net loss from continuing operations of $3.1 million, or $(0.09) per diluted share and adjusted net loss of $2.6 million, or $(0.08) per diluted share.

Comparable filing

the company's scale and our focus on operational efficiency across eXp World Holdings,” said Jesse Hill, Chief Financial Officer of eXp World Holdings. “We generated revenue of $1.0 billion and Adjusted EBITDA of $4.1 million, an 88% improvement that further strengthened our financial position. More recently, we executed the strategic NextHome acquisition using cash

Filing page SEC filing

CGBD

Carlyle Secured Lending Q1 NII $0.36/sh; NAV down 2.3% to $15.89; declares $0.35 dividend

Carlyle Secured Lending, Inc. May 11, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

• Revenues of $171.5 million, up 1.0%, primarily driven by 14% growth in our Global Electrical Systems segment. • Operating income of $14.7 million, which included $14.0 million gain on sale of assets, was up $13.3 million, compared to $1.4 million. Adjusted operating income of $2.0 million, relatively flat compared to $2.1 million. • Net income from continuing operations of $0.9 million, or $0.03 per diluted share and adjusted net loss of $3.4 million, or $(0.10) per diluted share, compared to net loss from continuing operations of $3.1 million, or $(0.09) per diluted share and adjusted net loss of $2.6 million, or $(0.08) per diluted share.

Comparable filing

For the first quarter of 2026, we reported $0.36 per common share of Net Investment Income and Adjusted Net Investment Income, a non-GAAP financial measure described below.

Filing page SEC filing

ENTXW

Entera Bio Q1 net loss $3.5M; cash $20.4M; EB613 Phase 3 protocol submitted to FDA

Entera Bio Ltd. May 8, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

• Revenues of $171.5 million, up 1.0%, primarily driven by 14% growth in our Global Electrical Systems segment. • Operating income of $14.7 million, which included $14.0 million gain on sale of assets, was up $13.3 million, compared to $1.4 million. Adjusted operating income of $2.0 million, relatively flat compared to $2.1 million. • Net income from continuing operations of $0.9 million, or $0.03 per diluted share and adjusted net loss of $3.4 million, or $(0.10) per diluted share, compared to net loss from continuing operations of $3.1 million, or $(0.09) per diluted share and adjusted net loss of $2.6 million, or $(0.08) per diluted share.

Comparable filing

Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptides, today reported financial results and key business updates for the quarter ended March 31, 2026.

Filing page SEC filing

RPC

Ridgepost Capital reports record AUM of $31B in Q1 2026, up 18% YoY

Ridgepost Capital, Inc. May 8, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

• Revenues of $171.5 million, up 1.0%, primarily driven by 14% growth in our Global Electrical Systems segment. • Operating income of $14.7 million, which included $14.0 million gain on sale of assets, was up $13.3 million, compared to $1.4 million. Adjusted operating income of $2.0 million, relatively flat compared to $2.1 million. • Net income from continuing operations of $0.9 million, or $0.03 per diluted share and adjusted net loss of $3.4 million, or $(0.10) per diluted share, compared to net loss from continuing operations of $3.1 million, or $(0.09) per diluted share and adjusted net loss of $2.6 million, or $(0.08) per diluted share.

Comparable filing

Ridgepost Capital, Inc (NYSE: RPC), a leading private markets solutions provider, today announced financial results for the first quarter ended March 31, 2026.

Filing page SEC filing

IVF

INVO Fertility FY2025 revenue $6.84M (+5% YoY); net loss improves to $(5.3)M

INVO Fertility, Inc. June 2, 2026, 8:40 AM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

• Revenues of $171.5 million, up 1.0%, primarily driven by 14% growth in our Global Electrical Systems segment. • Operating income of $14.7 million, which included $14.0 million gain on sale of assets, was up $13.3 million, compared to $1.4 million. Adjusted operating income of $2.0 million, relatively flat compared to $2.1 million. • Net income from continuing operations of $0.9 million, or $0.03 per diluted share and adjusted net loss of $3.4 million, or $(0.10) per diluted share, compared to net loss from continuing operations of $3.1 million, or $(0.09) per diluted share and adjusted net loss of $2.6 million, or $(0.08) per diluted share.

Comparable filing

and technologies, today announced fiscal year 2025 financial results. FY2025 Financial Highlights (all metrics compared to FY2024 unless otherwise noted) ● Revenue was $6,841,250, an increase of 5% compared to $6,532,000. ● Consolidated clinic revenue increased 4% to $6,721,057, compared to $6,450,431. ● Revenue from all clinics was $8,021,929, including

Filing page SEC filing

HAIN

Hain Celestial reports Q3 FY2026 earnings; detailed figures not included in filing excerpt

HAIN CELESTIAL GROUP INC May 11, 2026, 7:59 PM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

• Revenues of $171.5 million, up 1.0%, primarily driven by 14% growth in our Global Electrical Systems segment. • Operating income of $14.7 million, which included $14.0 million gain on sale of assets, was up $13.3 million, compared to $1.4 million. Adjusted operating income of $2.0 million, relatively flat compared to $2.1 million. • Net income from continuing operations of $0.9 million, or $0.03 per diluted share and adjusted net loss of $3.4 million, or $(0.10) per diluted share, compared to net loss from continuing operations of $3.1 million, or $(0.09) per diluted share and adjusted net loss of $2.6 million, or $(0.08) per diluted share.

Comparable filing

On May 11, 2026, The Hain Celestial Group, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended March 31, 2026.

Filing page SEC filing

HRTX

Heron Q1 net revenue $34.7M (-10.8% YoY); Acute Care up 32%; guidance reaffirmed

HERON THERAPEUTICS, INC. /DE/ May 11, 2026, 7:59 PM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

• Revenues of $171.5 million, up 1.0%, primarily driven by 14% growth in our Global Electrical Systems segment. • Operating income of $14.7 million, which included $14.0 million gain on sale of assets, was up $13.3 million, compared to $1.4 million. Adjusted operating income of $2.0 million, relatively flat compared to $2.1 million. • Net income from continuing operations of $0.9 million, or $0.03 per diluted share and adjusted net loss of $3.4 million, or $(0.10) per diluted share, compared to net loss from continuing operations of $3.1 million, or $(0.09) per diluted share and adjusted net loss of $2.6 million, or $(0.08) per diluted share.

Comparable filing

Reaffirms Guidance - Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF ® (+27%) and APONVIE ® (+50%) - Q1 2026 total net revenue of $34.7 million - Reached settlement with Baxter Healthcare Corporation in CINVANTI ® patent litigation - Reaffirmed 2026 full-year guidance of $173–$183 million net revenue; $10–$20 million

Filing page SEC filing

Source: SEC EDGAR
accession 0001628280-26-030670
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.